Canada’s leading 

Pharmaceutical

market access

strategy

consultancy

Our team of experts use their unique combination of real-world experience, technical skill, and nuanced understanding of the Canadian payer context to provide honest and practical guidance to our clients on navigating the market’s complexities.

SERVICES
OUR TEAM

  We partner with clients throughout the entire product lifecycle—from early-stage evidence development and strategy to reimbursement and post-market processes—delivering tailored, high-quality solutions that address each client’s unique needs. By integrating insights of key stakeholders across the healthcare ecosystem, we ensure our strategies drive meaningful impact and support long-term success.​

At MORSE CONSULTING we are focused on developing comprehensive reimbursement strategies that address our clients’ needs. Our vision for MORSE is to bridge the gap in perspectives and understanding between the key stakeholders in the market access space with the mutual objective of ensuring positive outcomes for patients and the health care system overall. MORSE has a unique opportunity to do this given the roles our team has had acting as or working with each stakeholder.

~ Sherry O'Quinn, Managing Principal
At MORSE CONSULTING we are focused on developing comprehensive reimbursement strategies that address our Clients’ needs. Our vision for MORSE is to bridge the gap in perspectives and understanding between the key stakeholders in the market access space with the mutual objective of ensuring positive outcomes for patients and the health care system overall. MORSE has a unique opportunity to do this given the roles our team have had acting as or working with each stakeholder.

~ Arvind Mani, Managing Director
At MORSE CONSULTING we are focused on developing comprehensive reimbursement strategies that address our Clients’ needs. Our vision for MORSE is to bridge the gap in perspectives and understanding between the key stakeholders in the market access space with the mutual objective of ensuring positive outcomes for patients and the health care system overall. MORSE has a unique opportunity to do this given the roles our team have had acting as or working with each stakeholder.

~ Sang Mi Lee, Executive Director
Previous slide
Next slide

MORSE Services

​We focus on being our Clients’ Strategy partner across the product’s life cycle from early-stage evidence strategy through reimbursement and post-market processes, complementing and enhancing the technical work done by submission dossier vendors. Our unique perspective and insights enable us to deliver tailored strategies that effectively engage key stakeholders in the healthcare ecosystem.

Comprehensive Market Access Launch Strategy

We provide specifically tailored support to help you ASSESS the landscape, MITIGATE risks, and OPTIMIZE market access success for your drugs, particularly for complex drugs including specialty, oncology and drugs for rare disease (DRDs). Our guidance will help you navigate the complexities of the Canadian healthcare system.

Market Access Landscape Analysis

We provide you with the insights needed to INFORM your strategy throughout your product launch life cycle. Our comprehensive analysis will equip you with a clear understanding of the market dynamics, facilitating informed decision-making.

HTA Planning and Reimbursement Evidence Strategy

Our real-world experience, technical skill, and nuanced understanding of the Canadian payer & HTA context enable us to provide expert guidance on HTA assessment and (re)submission strategies throughout your product launch life cycle. We ensure your product is well-positioned for success.

Negotiation & Stakeholder Engagement Strategy

Our unique understanding of Canadian payers will help you OPTIMIZE your approach, VALIDATE your position, and NAVIGATE challenges in negotiations with the pCPA and private payers. We serve as your trusted partner in fostering productive relationships with key stakeholders.

Portfolio & Life Cycle Strategy

Our deep expertise and unique insights into the Canadian market access landscape allow us to help you proactively PLAN and optimize your portfolio & life cycle challenges. Our strategic approach will help you maintain a strong market presence and adapt to evolving conditions.

Expert-Led Training & Customized Workshops

Our unparalleled expertise in the Canadian market access landscape enables us to offer a comprehensive suite of training programs and customized interactive workshops designed to PREPARE your team for success. We will equip your team with the knowledge and skills necessary to thrive in this dynamic environment.

About Our Services

MORSE Values

EXCELLENCE

We prioritize our team’s welfare and the quality of services and products we deliver to our clients while constantly looking for ways to improve.

INTEGRITY

We choose actions that reflect honesty and fairness: we honour our commitments and acknowledge our mistakes.

RESPECT

We communicate with openness, authenticity, kindness and respect and value the time, capability and intentions of everyone we work with.

COLLABORATION

We achieve success by building meaningful relationships and openly collaborating in the pursuit of excellence.

EXCELLENCE

We prioritize our team’s welfare and the quality of services and products we deliver to our clients while constantly looking for ways to improve.

INTEGRITY

We choose actions that reflect honesty and fairness: we honour our commitments and acknowledge our mistakes.

RESPECT

We communicate with openness, authenticity, kindness and respect and value the time, capability and intentions of everyone we work with.

COLLABORATION

We achieve success by building meaningful relationships and openly collaborating in the pursuit of excellence.

MORSE Reports

2024 edition of the Canadian Reimbursement and Forecasting Timelines (CRaFT) subscription, the new Drugs for Rare Diseases (DRD) Sub-Report and Oncology Market Access Trends & Insights report!

Learn More

MORSE Signals

Timely and relevant updates related to the emerging developments in the Canadian pharmaceutical reimbursement landscape.

CI’s 10th Pathways to Access Forum
Mastering Market Access
Sponsored by MORSE Consulting Inc.

March 2, 2025
-
Market Access News, Publications
The 2019 Real-World Evidence and Outcomes-Based Agreements Working Group research and outputs executive summary report is now available. The mission of the Real-World Evidence and Outcomes-Based Agreements Working Group is to advance the opportunity for the use of outcomes-based agreements in Canada.
Read More →
Posted by MORSE
1 MIN READ

Innovative Performance-based Agreement Structures for DRD’s

December 19, 2024
-
Market Access News, Publications
The 2019 Real-World Evidence and Outcomes-Based Agreements Working Group research and outputs executive summary report is now available. The mission of the Real-World Evidence and Outcomes-Based Agreements Working Group is to advance the opportunity for the use of outcomes-based agreements in Canada.
Read More →
Posted by MORSE
1 MIN READ

Accelerating Access: Leveraging Target Zero to Expedite Time to Access for New Therapies

October 2, 2024
-
Market Access News, Publications
On September 5th, 2024, Katherine Scott and Lana Duan from MORSE Consulting presented “Accelerating Access: Leveraging Target Zero to Expedite Time to Access for New Therapies” at the…
Read More →
Posted by MORSE
1 MIN READ
All Morse Signals

MORSE Careers

We are always looking for bright, passionate, and motivated individuals, so check out our open positions or send us your resumé.

Career Opportunity at MORSE for Consultant, Health Technology Assessment

July 4, 2023
-
Careers, What's New
We are seeking an individual with similar values, a passion for learning and an interest in making a meaningful contribution to consulting projects and our overall...
Read More →
Posted by MORSE
7 MIN READ
All Morse Careers
MORSE Consulting Inc. - Deciphering Pharmaceutical Market Access
Learn More